AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2021
Jul 19, 2021
34117_dirs_2021-07-19_bd3230a3-1a1b-4f2e-aa26-be214c67d96c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anixa Biosciences Inc (ANIX)
CIK: 0000715446
Period of Report: 2021-07-15
Reporting Person: Titterton Lewis H jr (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-15 | Common Stock | P | 2200 | $3.65 | Acquired | 895826 | Direct |
| 2021-07-16 | Common Stock | P | 10000 | $4.07 | Acquired | 905826 | Direct |
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6